Sanofi walks away from Regulus` kidney disease therapy
19 Jul 2022 //
FIERCEBIOTECH
Regulus Completes Enrollment in Phase 2 Trial of Lademirsen for Alport Syndrome
24 Feb 2022 //
PRNEWSWIRE
19 Jul 2022 //
FIERCEBIOTECH
24 Feb 2022 //
PRNEWSWIRE